| Literature DB >> 28073819 |
Jason R Pryor1,2, Faouzi I Maalouf1,2, Elizabeth E Krans3, Robert E Schumacher4, William O Cooper1,5,6, Stephen W Patrick1,2,5,6.
Abstract
As the prescription opioid epidemic grew in the USA, its impact extended to pregnant women and their infants. This review summarises how increasing rates of neonatal abstinence syndrome resulted in a need to improve care to pregnant women and opioid-exposed infants. We discuss the variations in care delivery with particular emphasis on screening at-risk mothers, scoring systems for neonatal drug withdrawal, type and duration of pharmacotherapy, and discharge safety. Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://www.bmj.com/company/products-services/rights-and-licensing/.Entities:
Keywords: Drug Withdrawal; Neonatology
Mesh:
Substances:
Year: 2017 PMID: 28073819 PMCID: PMC5730450 DOI: 10.1136/archdischild-2015-310045
Source DB: PubMed Journal: Arch Dis Child Fetal Neonatal Ed ISSN: 1359-2998 Impact factor: 5.747